Is Immunoprecise Antibodies Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 2 Wall Street analysts covering (NASDAQ: IPA) stock is to Buy IPA stock.
Out of 2 analysts, 0 (0%) are recommending IPA as a Strong Buy, 2 (100%) are recommending IPA as a Buy, 0 (0%) are recommending IPA as a Hold, 0 (0%) are recommending IPA as a Sell, and 0 (0%) are recommending IPA as a Strong Sell.
According to 2 Wall Street analysts that have issued a 1 year IPA price target, the average IPA price target is $8.00, with the highest IPA stock price forecast at $9.00 and the lowest IPA stock price forecast at $7.00.
On average, Wall Street analysts predict that Immunoprecise Antibodies's share price could reach $8.00 by Sep 18, 2024. The average Immunoprecise Antibodies stock price prediction forecasts a potential upside of 306.09% from the current IPA share price of $1.97.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.